| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |